Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bowling Alleys and Tornadoes: G&K Hunting Grounds -- Ignore unavailable to you. Want to Upgrade?

To: Percival 917 who wrote (44)	7/18/1999 9:45:00 PM
From: snoozlooze	Respond to of 153

Joel, Thanks for a good explanation of the VISX issues. Hope the best for your father. snooz

To: Percival 917 who wrote (44)	7/19/1999 12:24:00 AM
From: Mike Buckley	Respond to of 153

Joel, The Ophthalmologists keep paying the royalty but everyone I know hates it and would switch if another laser came along as good as VISIX. As I understand it, there is a significant though not prohibitive cost of switching. The equipment costs about $250,000 if I remember properly. If another product does come along that is just as good, the chances are that the provider would require a high royalty also, having seen the Visiix's successful business model. On the other hand, if they introduce the as good or better product at lower rates, Visix would be able to reduce their royalties. Certainly one of the characterisitcs of a potential gorilla is the ability to raise and lower prices at will. We know that Visix can raise prices. It will be interesting to see if they can also lower prices successfully. --Mike Buckley